RTI-274
File:RTI-274 Structure.png | |
Systematic (IUPAC) name | |
---|---|
2β-([3,4-Methylenedioxy)phenoxy]methyl)-3α-(4-fluorophenyl)nortropane
|
|
Chemical data | |
Formula | C21H22FNO3 |
Molecular mass | 355.402 g/mol |
|
|
(verify) |
RTI-274, or 2β-((3,4-Methylenedioxyphenoxy)methyl)-3α-(4-fluorophenyl)nortropane is a phenyltropane homologue of paroxetine developed by the group led by F Ivy Carroll in the 1990s.[1]
Introduction
Very few ethers of phenyltropanes are actually known to have been reported.
NS2330 and NS2359 both have α,β stereochemistry.
NS2214 appears to have been abandoned now, RTI-336 was their latest compound.
RTI decided that they wanted to make all 8 stereoisomers of the phenyltropane paroxetine homolog.[1]
MAT IC50 (nM) Nor/tropane-Paroxetine Hybrids | ||||
Compound | [3H]CFT | [3H]Paroxetine | [3H]Nisoxetine | |
Paroxetine | ? → 623 | ? → 0.28 | ? → 535 | |
R | "β,β" | 308 → 835 | 294 → 480 | 5,300 → 37,400 |
α,β | 172 → 142 | 52.9 → 90 | 26,600 → 2,500 | |
β,α | 3.01 → 3.86 | 422 → 5.62 | 123 → 14.4 | |
S | "β,β" | 1,050 → 1,210 | 88.1 → 424 | 27,600 → 17,300 |
α,β | 1,500 → 27.6 | 447→ 55.8 | 2,916 → 1,690 | |
β,α | 298 → 407 | 178 → 19 | 12,400 → 1,990 |
- N-demethylating the S-α,β (1S,2S,3R) isomer resulted in a 54-fold increase in DAT IC50.
In the case of nocaine it is understood that the SR enantiomer is the one that should be demethylated if it is wanted to improve DAT affinity.
Interestingly, that is actually the same enantiomer that is used in the production of paroxetine.
Skeletal rearrangement
Four years later some unrelated authors cited a skeletal rearrangement accounts for this.[2] Diagram[dead link]
Notice that they are not only interested in ethers, but nitrogen containing Nu's ("TRODAT") {p948, 24}.
The metal is called "Technetium" and is bound by a chelating agent.
The authors state that at first the acid is halogenated, the amide is prepared, and reduced.
Erratum
(a) (1) 1-chloroethyl chloroformate, 1,2-dichloroethane, reflux; (2) MeOH reflux; (b) p-toluenesulfonyl chloride, triethylamine; (c) LiAlH4, THF, rt; (d) trifluoromethanesulfonic anhydride, pyridine, CH2Cl2; (e) Na, sesamol, THF; (f) 5% Na/Hg amalgam, Na2HPO4, MeOH.
MAT IC50 (Ki) N-Methyl → De-methyl | |||
Compound | [3H]CFT | [3H]Nisoxetine | [3H]paroxetine |
R-β,β | ? → 3 | ? → 2 (0.2) | ? → 6 (4) |
S-β,β | ? → ? | ? → ? (?) | ? → ? (?) |
R-"nonane" | 308 → 835 | 294 (27) → 480 (44) | 5,300 (3200) → 37,400 (22,500) |
S-"nonane" | 1050 → 1210 | 88 (8) → 424 (39) | 27,600 (16,600) → 17,300 (10,400) |
To solve the problem of the unexpected aza-bicyclo[3.2.2]nonane rearrangement product, the original synthesis had to be modified as follows;[3] WIN 35428 was N-demethylated and then the NH amine was reacted with a suitable protecting group so that N is no longer nucleophilic. In their case they used a tosyl. (Satendra Singh, 2000) Page 952
See also
References
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles with dead external links from August 2011
- Organofluorides
- Tropanes
- RTI compounds
- Dopamine reuptake inhibitors
- Stimulants
- Sympathomimetic amines
- Benzodioxoles